openPR Logo
Press release

Adult Growth Hormone Deficiency Market Size, Epidemiology, Pipeline, Therapies, Companies and Competitive Analysis by DelveInsight

06-08-2022 09:08 AM CET | Health & Medicine

Press release from: DelveInsight

Adult Growth Hormone Deficiency Market

Adult Growth Hormone Deficiency Market

Adult Growth Hormone Deficiency (AGHD) is a medical condition that occurs when the pituitary gland in brain does not produce enough growth hormone. Most cases of Adult Growth Hormone Deficiency (AGHD) result from damage to the pituitary gland caused by a pituitary tumor or by treatment for this using surgery and/or radiotherapy. Adult Growth Hormone Deficiency (AGHD) is treated with growth hormone replacement therapy. The growth hormone that is used is an artificial preparation that individuals can administer themselves.

DelveInsight's "Adult Growth Hormone Deficiency Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Adult Growth Hormone Deficiency, historical and forecasted epidemiology as well as the Adult Growth Hormone Deficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Get detailed report here: https://www.delveinsight.com/report-store/adult-growth-hormone-deficiency-aghd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some facts of Adult Growth Hormone Deficiency Market are:
• According to D B Allen et al., about 15%-20% of the cases represent the transition of childhood GH deficiency into adulthood.
• As per Jana Bujanova et al., estimates prevalence of AGHD in the UK is approximately 1 in 10 000 (a total of approximately 6380 patients). If Childhood-onset GH deficiency is added to this number then prevalence is 1 in 10 000 to 1 in 3500.
• In a study, the author found that a greater proportion of Japanese adults had AO GHD than CO GHD, a finding similar to those of previous studies in Caucasian adults. In contrast, in a previous study of Japanese adults with GHD, only 45% of participants were reported to have AO GHD. That study, however, included a smaller number of participants than were included in the study and was conducted at a single institution. [Akira Shimatsu et al.,2011]
• Adult Growth Hormone Deficiency is more common among males than females.

Get detailed report here: https://www.delveinsight.com/report-store/adult-growth-hormone-deficiency-aghd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Scope of the Adult Growth Hormone Deficiency Market Report
• The report covers the descriptive overview of Adult Growth Hormone Deficiency, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies.
• Comprehensive insight has been provided into the Adult Growth Hormone Deficiency epidemiology and treatment in the 7MM.
• Additionally, an all-inclusive account of both the current and emerging therapies for Adult Growth Hormone Deficiency is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape.
• A detailed review of the Adult Growth Hormone Deficiency market; historical and forecasted is included in the report, covering drug outreach in the 7MM.
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Adult Growth Hormone Deficiency market.

Get detailed report here: https://www.delveinsight.com/report-store/adult-growth-hormone-deficiency-aghd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of Adult Growth Hormone Deficiency Companies are:
• Novo Nordisk
• Ascendis Pharma
• And Many Others

Some of Adult Growth Hormone Deficiency Therapies are:
• Sogroya (somapacitan-beco)
• TransCon hGH
• And Many Others

Get free sample report here: https://www.delveinsight.com/sample-request/adult-growth-hormone-deficiency-aghd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents:
1. Key Insights
2. Executive Summary of Adult Growth Hormone Deficiency
3. Competitive Intelligence Analysis for Adult Growth Hormone Deficiency
4. Adult Growth Hormone Deficiency: Market Overview at a Glance
5. Adult Growth Hormone Deficiency: Disease Background and Overview
5.1. Introduction
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Adult Growth Hormone Deficiency Treatment
11. Marketed Products
List to be continued in report
12. Emerging Therapies
List to be continued in report
13. Adult Growth Hormone Deficiency: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Adult Growth Hormone Deficiency
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
20.1. Bibliography
20.2. Report Methodology
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight

Request for Detailed TOC: Get free sample report here: https://www.delveinsight.com/sample-request/adult-growth-hormone-deficiency-aghd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of Newly Launched Report:
NCFB Market
https://www.delveinsight.com/report-store/non-cystic-fibrosis-bronchiectasis-ncfb-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Metastatic Bone Pain Market
https://www.delveinsight.com/report-store/metastatic-bone-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Ventricular Hypertrophy Market
https://www.delveinsight.com/report-store/ventricular-hypertrophy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Diagnostic Imaging Equipment Market
https://www.delveinsight.com/report-store/diagnostic-imaging-equipment-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Invasive Candidiasis Market
https://www.delveinsight.com/report-store/invasive-candidiasis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Upper Limb Hypertonia Market
https://www.delveinsight.com/report-store/upper-limb-hypertonia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Sialidosis Market
https://www.delveinsight.com/report-store/sialidosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Filgrastim Biosimilar Insight
https://www.delveinsight.com/report-store/filgrastim-biosimilar-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com

About Delveinsight:
DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Adult Growth Hormone Deficiency Market Size, Epidemiology, Pipeline, Therapies, Companies and Competitive Analysis by DelveInsight here

News-ID: 2647076 • Views:

More Releases from DelveInsight

Insulin Resistance Pipeline Insight 2025: Pipeline Drugs, Metabolic Pathway Modulators, and Novel Therapeutics Redefine Future Care | DelveInsight
Insulin Resistance Pipeline Insight 2025: Pipeline Drugs, Metabolic Pathway Modu …
DelveInsight's "Insulin Resistance - Pipeline Insight, 2025" explores over 10+ therapies in development for insulin resistance, a metabolic condition strongly linked to type 2 diabetes, obesity, and cardiovascular disease. Despite lifestyle modification and insulin-sensitizing drugs like metformin being mainstays of management, many patients continue to face poor glycemic control and associated complications, underscoring the need for more effective insulin resistance treatments. The insulin resistance pipeline is broadening with next-generation therapies targeting
Uveal Melanoma Pipeline Insight 2025: 30+ Pipeline Drugs, Targeted Therapies, and Immuno-Oncology Strategies Drive Innovation | DelveInsight
Uveal Melanoma Pipeline Insight 2025: 30+ Pipeline Drugs, Targeted Therapies, an …
DelveInsight's "Uveal Melanoma - Pipeline Insight, 2025" explores over 30+ therapies in development for uveal melanoma, a rare and aggressive intraocular malignancy with high metastatic potential, most commonly to the liver. Despite surgery and radiotherapy being standards for localized disease, patients with metastatic uveal melanoma face limited systemic treatment options, creating significant unmet needs in the uveal melanoma treatment landscape. The uveal melanoma pipeline is diversifying with next-generation targeted therapies, including
Peptic Ulcers Pipeline Insight 2025: Emerging Therapies and Clinical Trials Shaping Next-Generation Peptic Ulcer Disease Treatments | DelveInsight
Peptic Ulcers Pipeline Insight 2025: Emerging Therapies and Clinical Trials Shap …
DelveInsight's "Peptic Ulcers - Pipeline Insight, 2025" examines over 8+ therapies in development for peptic ulcer disease, a condition affecting millions worldwide with peptic ulcer disease symptoms such as abdominal pain, bloating, nausea, and gastrointestinal bleeding. Despite widespread use of existing peptic ulcer disease treatments, including proton pump inhibitors, H2 blockers, and antibiotics for H. pylori eradication, patients with recurrent or complicated peptic ulcers continue to face significant unmet needs,
Vaso-Occlusive Crisis in Sickle Cell Disease: Emerging Therapies, Clinical Trials, and Pipeline Innovations Shaping the Future of Treatment - 2025 | DelveInsight
Vaso-Occlusive Crisis in Sickle Cell Disease: Emerging Therapies, Clinical Trial …
DelveInsight's "Vaso-Occlusive Crisis (VOC) Associated With Sickle Cell Disease - Pipeline Insight, 2025" provides an in-depth analysis of emerging therapies targeting vaso-occlusive crisis (VOC), a severe and recurring complication of sickle cell disease. Despite current standards of care, including hydroxyurea, patients continue to experience frequent vaso occlusive sickle cell crisis, underscoring the urgent need for effective interventions in sickle cell anemia vaso occlusive crisis treatment. The VOC pipeline is diversifying with

All 5 Releases


More Releases for Adult

Digital Adult Content Market Size Analysis by Application, Type, and Region: For …
USA, New Jersey- According to Market Research Intellect, the global Digital Adult Content market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period. Due to rising internet accessibility, smartphone adoption, and a move toward subscription-based digital platforms, the market for digital adult content has grown steadily.
Prominent Adult Entertainment Market Trend for 2025: AI-Driven Innovations In Ad …
"What Are the Projected Growth and Market Size Trends for the Adult Entertainment Market? In recent times, the adult entertainment market has seen substantial expansion. The market size is set to increase from $65.95 billion in 2024 to $71.95 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.1%. The notable growth during the historic period is owed largely to a combination of factors. These include a wider acceptance
Adult Day Care Services Market Overall Study Report 2024-2031 | Active Day/Senio …
Adult Day Care Services Market Trends Overview 2024-2031: The latest report by Coherent Market Insights, titled "Adult Day Care Services Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2031," provides an in-depth analysis of the industry, offering valuable insights into the dynamics of the Adult Day Care Services market. The report features a detailed examination of competitive and regional trends, alongside recent advancements shaping the market landscape. The report includes a
Adult Diapers Market - A New Standard of Care: Transformative Diapers Redefining …
Newark, New Castle, USA: The "Adult Diapers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Adult Diapers Market: https://www.growthplusreports.com/report/adult-diapers-market/7749 This latest report researches the industry structure, sales, revenue,
Adult Gastroenterology Associates Consolidates Offices
Adult Gastroenterology Associates (AGA), founded in 1987 and still the only independent gastroenterology practice in Tulsa, is combining all of their practices under one roof in the Richmond Plaza Building. The new location at 4200 E. Skelly Drive will be in the same building as the Tulsa Endoscopy Center, a partner company of AGA. The team members at AGA pride themselves on being completely centered on their patients and what
Adult Toys Market
The global Adult Toys market is valued at 16200 million US$ in 2018 and will reach 34100 million US$ by the end of 2025, growing at a CAGR of 9.8% during 2019-2025. The Market Insights Reports has published the obtainability of a new statistical data to its repository titled as, Adult Toys Market. The report provides useful insights into a wide range of business aspects such as pillars, features, sales strategies,